Anavex Life Sciences Corp (AVXL)

[Gator328]

If the price can hold $23 for the next few days, it may be setting a new floor prior to its next move up. All dependent on positive data of course.

I personally believe any company with a promising but unapproved drug and zero revenue shouldn’t be worth more than $500 million market cap, but everything is overinflated in the current market.

$30 looks like it may happen in the next few weeks if there’s a good Rett update.